Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 04 symbols : Jnj save search
Xencor and Janssen Unite Again in Second Bispecific Antibodies Agreement
Published: 2021-10-04 (Crawled : 22:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
antibody
Bentley University Announces Vaccination Requirement for Home Indoor Athletic Events
Published: 2021-10-04 (Crawled : 20:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.4%
H: 0.78%
C: -0.18%
vaccine
Novavax Announces Leadership Appointment and Updates
Published: 2021-10-04 (Crawled : 20:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.4%
H: 0.78%
C: -0.18%
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 1.81%
H: 2.04%
C: -6.34%
COVID-19 Update: J&J to Request Booster Authorization, Merck Antiviral Review a Priority
Published: 2021-10-04 (Crawled : 17:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
covid antiviral authorized covid-19
Global Molecular Diagnostics Markets Analysis & Forecasts, 2016-2020 & 2021-2026 with COVID-19 Impact Insights
Published: 2021-10-04 (Crawled : 16:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.2%
H: 0.52%
C: -0.45%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.02%
H: 0.26%
C: -0.69%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: -0.19%
H: 0.62%
C: -1.05%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: -0.44%
H: 1.51%
C: -1.26%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.51%
H: 0.82%
C: -0.93%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.02%
H: 0.26%
C: -0.69%
covid molecular diagnostics molecular diagnostics diagnostic
Clinical Catch-Up: September 27-October 1
Published: 2021-10-04 (Crawled : 14:15) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.54%
H: 0.77%
C: 0.17%
New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA® (ustekinumab) in Older Patients Across Approved Indications
Published: 2021-10-04 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
europe order
Adamis Announces Appointment of Meera Desai, Ph.D., to Board of Directors
Published: 2021-10-04 (Crawled : 12:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
NKTR | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: 2.74%
H: 1.58%
C: -1.58%
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 3.98%
H: 3.96%
C: 2.97%
Xencor Enters Global Collaboration and License Agreement With Janssen to Advance Plamotamab and XmAb CD28 Bispecific Antibody Combinations for the Treatment of Patients With B-Cell Malignancies
Published: 2021-10-04 (Crawled : 12:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 2.87%
H: 5.64%
C: 5.37%
treatment collaboration antibody license t-cell
Active Pharmaceutical Ingredient (API) Market to Cross $357,005.7 Million Value by 2030, says P&S Intelligence
Published: 2021-10-04 (Crawled : 10:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.49%
H: 0.0%
C: -0.77%
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 6.28%
H: 0.0%
C: -0.2%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: -1.95%
H: 2.51%
C: 0.73%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.28%
H: 0.49%
C: -1.16%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.83%
H: 1.0%
C: 0.15%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.1%
H: 1.02%
C: 0.37%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.53%
H: 1.05%
C: -1.29%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.13%
H: 1.05%
C: -0.79%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.71%
H: 1.25%
C: -0.1%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.54%
H: 0.77%
C: 0.17%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.28%
H: 0.83%
C: 0.82%
Addex to Present at the 10th International Meeting on Metabotropic Glutamate Receptors
Published: 2021-10-04 (Crawled : 06:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.